Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Nature Communications
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. nature communications
  3. articles
  4. article
Engineering B cells to express fully customizable antibodies with enhanced Fc functions
Download PDF
Download PDF
  • Article
  • Open access
  • Published: 13 May 2026

Engineering B cells to express fully customizable antibodies with enhanced Fc functions

  • Chun Huang1,
  • Atishay Mathur  ORCID: orcid.org/0009-0002-6872-944X1,
  • Chan-Hua Chang1,
  • Xiaoli Huang1,
  • Hsu-Yu Chen1,
  • Zachary B. Davis2,
  • Karla O’Dell3,
  • Elizabeth A. Shuman3,
  • Raymond W. Kung3,
  • Geoffrey L. Rogers  ORCID: orcid.org/0000-0002-9183-12691 &
  • …
  • Paula M. Cannon  ORCID: orcid.org/0000-0003-0059-354X1 

Nature Communications (2026) Cite this article

  • 975 Accesses

  • 4 Altmetric

  • Metrics details

We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.

Subjects

  • B-cell receptor
  • Genomic engineering
  • Immunization
  • Molecular medicine

Abstract

Genome editing within the constant region of the immunoglobulin Heavy chain locus (IGH) can reprogram B cells to express heavy-chain-only antibodies (HCAbs) containing custom antigen-recognition domains. HCAb-engineered cells express both surface B cell receptor (BCR) and secreted antibody isoforms and respond to antigen. Here, we extend this approach to also allow customization of the constant (Fc) domain of the Heavy chain by selecting alternate editing sites within IGH, producing HCAbs with enhanced effector functions or containing mutations to extend antibody half-life. We also introduced mutations to force obligate HCAb homodimers and prevent unwanted pairing with endogenous antibody chains. Finally, we showed that additional domains could be accommodated at the HCAb C-terminus and preferentially expressed in the secreted isoform. Together, these data demonstrate the flexibility of the HCAb editing platform to express fully customized molecules that take advantage of the properties of B cells.

Similar content being viewed by others

Reprogramming human B cells with custom heavy-chain antibodies

Article 22 July 2024

Structural principles of B cell antigen receptor assembly

Article 13 October 2022

Human CD4-binding site antibody elicited by polyvalent DNA prime-protein boost vaccine neutralizes cross-clade tier-2-HIV strains

Article Open access 21 May 2024

Acknowledgements

P.M.C. discloses support for the research of this work from National Institutes of Health grants U19 HL156247, UM1 AI164561, P01 HL183483 and R01 AI167003. A.M. discloses support for the research of this work from National Institutes of Health grant F30 AI186662. Tonsil tissue was collected and processed by the Norris Comprehensive Cancer Center Translational Pathology Core, supported by National Cancer Institute grant P30 CA014089. The remaining authors declare no relevant funding.

Author information

Authors and Affiliations

  1. Department of Immunology and Immune Therapeutics, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA

    Chun Huang, Atishay Mathur, Chan-Hua Chang, Xiaoli Huang, Hsu-Yu Chen, Geoffrey L. Rogers & Paula M. Cannon

  2. Department of Medicine, University of Minnesota, Minneapolis, MN, USA

    Zachary B. Davis

  3. Department of Otolaryngology–Head & Neck Surgery, University of Southern California, Los Angeles, CA, USA

    Karla O’Dell, Elizabeth A. Shuman & Raymond W. Kung

Authors
  1. Chun Huang
    View author publications

    Search author on:PubMed Google Scholar

  2. Atishay Mathur
    View author publications

    Search author on:PubMed Google Scholar

  3. Chan-Hua Chang
    View author publications

    Search author on:PubMed Google Scholar

  4. Xiaoli Huang
    View author publications

    Search author on:PubMed Google Scholar

  5. Hsu-Yu Chen
    View author publications

    Search author on:PubMed Google Scholar

  6. Zachary B. Davis
    View author publications

    Search author on:PubMed Google Scholar

  7. Karla O’Dell
    View author publications

    Search author on:PubMed Google Scholar

  8. Elizabeth A. Shuman
    View author publications

    Search author on:PubMed Google Scholar

  9. Raymond W. Kung
    View author publications

    Search author on:PubMed Google Scholar

  10. Geoffrey L. Rogers
    View author publications

    Search author on:PubMed Google Scholar

  11. Paula M. Cannon
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Paula M. Cannon.

Ethics declarations

Competing interests

Intellectual property discussed in this paper has been licensed by Be Biopharma from the University of Southern California. P.M.C. is a compensated member of Be Biopharma’s Scientific Advisory Board. The remaining authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Supplementary Information (download PDF )

Description of Additional Supplementary Files (download PDF )

Supplementary Data 1 (download XLSX )

Supplementary Data 2 (download XLSX )

Supplementary Data 3 (download XLSX )

Reporting Summary (download PDF )

Transparent Peer Review File (download PDF )

Source data

Source Data (download XLSX )

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Huang, C., Mathur, A., Chang, CH. et al. Engineering B cells to express fully customizable antibodies with enhanced Fc functions. Nat Commun (2026). https://doi.org/10.1038/s41467-026-72991-8

Download citation

  • Received: 26 August 2025

  • Accepted: 27 April 2026

  • Published: 13 May 2026

  • DOI: https://doi.org/10.1038/s41467-026-72991-8

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Download PDF

Advertisement

Explore content

  • Research articles
  • Reviews & Analysis
  • News & Comment
  • Videos
  • Collections
  • Subjects
  • Follow us on Facebook
  • Follow us on X
  • Sign up for alerts
  • RSS feed

About the journal

  • Aims & Scope
  • Editors
  • Journal Information
  • Open Access Fees and Funding
  • Calls for Papers
  • Editorial Values Statement
  • Journal Metrics
  • Editors' Highlights
  • Contact
  • Editorial policies
  • Top Articles

Publish with us

  • For authors
  • For Reviewers
  • Language editing services
  • Open access funding
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Nature Communications (Nat Commun)

ISSN 2041-1723 (online)

nature.com footer links

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2026 Springer Nature Limited

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing